Investigative Mathematical Modeling of Hospital Transmission of Hepatitis C
NCT02826447 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 550
Last updated 2017-04-10
Summary
This project is a prospective observational cohort study to quantify the risk of acquiring Hepatitis C virus (HCV) infection for patients and healthcare workers in Ain Shams University Teaching Hospital, Cairo, Egypt through: 1) identifying typical patient trajectories within the hospital; and 2) assessing the ward-specific risk based on the type and number of procedures performed and the prevalence of HCV viremia in patients within each ward.
Conditions
- Exposure to Hepatitis C Virus
Sponsors & Collaborators
-
Conservatoire national des Arts et Métiers
collaborator OTHER -
Ain Shams University
collaborator OTHER -
Institut Pasteur
collaborator INDUSTRY -
ANRS, Emerging Infectious Diseases
lead OTHER_GOV
Principal Investigators
-
Laura Temime, Professor · Conservatoire national des Arts et Métiers
-
Wagida Anwar, Professor · Ain Shams University
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-02-21
- Primary Completion
- 2018-04-30
- Completion
- 2018-04-30
Countries
- Egypt
Study Locations
More Related Trials
-
Pegylated Interferon and Ribavirin Therapy in Chronic Hepatitis Genotype 4
NCT00277862 ·Status: COMPLETED ·Phase: PHASE4
-
Oral Microbiome of Patients With Hepatitis C Virus Infection
NCT03682549 ·Status: COMPLETED
-
Use of Direct-acting Antiviral to Treat HCV Recurrence After Liver Transplantation (ANRSCO23CUPILT) Infection
NCT01944527 ·Status: UNKNOWN
-
Chronic Hepatitis C Treatment by Pegylated Interferon and Ribavirin in Naive Egyptian Patients (ANRS 1211)
NCT00158496 ·Status: COMPLETED ·Phase: PHASE3
-
Feasibility of Implementing a Cohort of People Living With Hepatitis C in Vietnam
NCT03601546 ·Status: UNKNOWN
-
Impact of Interferon Free Regimens in Patients With Chronic HCV and Successfully Treated HCC
NCT02771405 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Sofosbuvir-Based Regimens in the Treatment of Egyptian Patients With Hepatitis C Infection
NCT02992457 ·Status: COMPLETED ·Phase: PHASE4
-
Identification of Viral Variants Involved in the Transmission of Hepatitis C and Characterization of Antigenic and Functional Properties of Their Envelope Glycoproteins
NCT02574884 ·Status: COMPLETED ·Phase: NA
-
Access to Hepatitis C Treatment in Cameroon: Comparison of a Simplified Test and Treat Strategy to a Standard Strategy
NCT07098481 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Pilot Study on the Feasibility of Systematic Hepatitis C Screening of Hospitalized Patients
NCT04405024 ·Status: SUSPENDED ·Phase: NA
-
Intravenous Interferon During Liver Transplant
NCT01192698 ·Status: COMPLETED ·Phase: NA
-
Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) in Patients Who Have Previously Not Received the Standard of Care
NCT01359644 ·Status: COMPLETED ·Phase: PHASE2
-
Y- Shaped Pegylated Interferon (YPEG-IFNα-2a) Plus Ribavirin in Egyptian Patients With Untreated Chronic Hepatitis C
NCT01327729 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Phase 1/2 Study of CF102 in Patients With Chronic Hepatitis C Genotype 1
NCT00790673 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Genotype 4 (GT4) Hepatitis C Virus (HCV) in Egypt
NCT02247401 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Albumin Interferon Administered Every 4 Weeks in Genotype 2/3 Hepatitis C Patients
NCT00759200 ·Status: COMPLETED ·Phase: PHASE2
-
Sofosbuvir and Simeprevir Versus Sofosbuvir and Ribavirin in Treatment of HCV
NCT03069001 ·Status: COMPLETED ·Phase: PHASE4
-
Pilot Study to Assess Efficacy and Safety of a Triple Therapy With Asunaprevir, Daclatasvir, and BMS-791325 in HCV Genotype 4-infected Patients After Failure of Pegylated Interferon-Ribavirin Regimen
NCT02309450 ·Status: WITHDRAWN ·Phase: PHASE2
-
Efficacy Study of New Therapeutic Schedules in Naive Hepatitis C Virus (HCV) Patients Infected With Genotype 3 (HCV-3)
NCT01121705 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available Medications
NCT01455090 ·Status: COMPLETED ·Phase: PHASE2
-
Does Hepatitis C Management Protect Egyptian Population Against Severe Corona Virus Disease-2019?
NCT04757272 ·Status: COMPLETED
-
Therapeutic Option for Hepatitis B and C: a French Cohort
NCT01953458 ·Status: UNKNOWN
-
Improving Inpatient Screening for Hepatitis C
NCT04525690 ·Status: COMPLETED ·Phase: NA
-
Qualification of Point-of-Care Assays for Management of HCV Patients
NCT02335320 ·Status: UNKNOWN
-
Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care
NCT01012895 ·Status: COMPLETED ·Phase: PHASE2